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 L. acidophilus DDS1-10 was encapsulated using an alginate, potato starch and type 4 
resistant starch (RS4) matrix. The wall material was optimized by varying levels of 
alginate (1.6 to 4.4%), while maintaining potato starch and RS4 ratio fixed at 2, and the 
total solid content at 5%.  Particles were prepared using an emulsion and an extrusion 
method. Particles obtained from the emulsion method were smaller with a non-uniform 
distribution in size while those obtained by the extrusion method were bigger and 
uniform in size. The emulsion method did not seem to offer protection to the probiotic 
cells against pH, bile salt and temperature. However, the particles obtained by the 
extrusion method provided protection against the effects of pH and bile salts. The 
particles produced by extrusion were incorporated into two food systems of varying pH 
levels. Promising results were observed in the milk system; however encapsulation did 
not provide significant protection when cells were introduced to acai juice during 16 days 
of storage.  
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Chapter 1. Literature review 
1.1 Microencapsulation 
Microencapsulation is the process by which food ingredients, enzymes, cells or other 
materials are incorporated in small capsules (Gibbs et al. 1999). The capsule coatings are 
referred to as wall, shell, or carrier. The entrapped material can be described as the core, 
fill, actives, or payload (Augustin et al. 2001). Microencapsulation first appeared in the 
market as part of the manufacturing process of carbonless copy paper (White 1998).  
 
During encapsulation, the core material is usually enclosed by the wall material. 
Sometimes, there is no obvious boundary between the wall and core material, with both 
mixed together in what is called the matrix. The shape of the particles can be regular or 
irregular. Since the particle is usually spherical to elliptical, it is also called a 
microsphere. If the capsule has a gel-like structure, it is named gel-bead (Amir 
Mortazavian 2007; Gibbs et al. 1999; Gouin 2004). The surface of the particles can be 
smooth or rough. There might also be cracks on the particles (Sheu and Marshall 1993). 
The surface of the particles can be porous too, which usually lower the encapsulation 
efficiency (Amir Mortazavian 2007). In this case, a second wall or multi-walls can be 
used to strengthen the inner wall and increase the encapsulation efficiency (Krasaekoopt 
et al. 2004).  
 
 
 
 
The size of the particles varies with the method applied for encapsulation. Smaller sizes 
are preferred because they allow for better transportation of nutrients and oxygen, better 
mechanical strength and better dispersion (Chicheportiche and Reach 1988; Leblond et 
al. 1999). Singer and Dunn (1990) reported that particles that are smaller than 3 µm are 
not perceived by the tongue. 
 
Microencapsulation is used for several different reasons. It is used to protect the 
compound or biological cells from the surrounding environment (heat, oxygen, moisture); 
disguise unpleasant odor, color or taste of the core material, or convert liquid into powder 
for ease of handling. It can also be used to better disperse core materials in the product; 
and  control the release of the core material at supposed sites and times (Desai and Park 
2005; Dziezak 1988(Desai and Park 2005; Dziezak 1988; Shahidi and Han 1993). 
 
1.2 Microencapsulation techniques 
There are various techniques available for microencapsulation. They are normally 
classified into three categories: (1) Physical techniques (Spray drying, spray chilling, 
extrusion, centrifugal extrusion, fluid bed coating); (2) Chemical techniques (Interfacial 
polymerization, polymerization); and (3) Physicochemical techniques (Coacervation). 
The choice of method is dependent mainly on the wall material, core material, equipment 
available, cost consideration, application, and scale of production (Gibbs et al. 1999; 
 
 
 
Gouin 2004; Krasaekoopt et al. 2004). Table 1.1 shows the advantages and disadvantages 
of some of the encapsulation techniques, while Table 1.2 shows the major processes 
involved in some of the encapsulation techniques.  
 
1.2.1 Emulsion method 
The emulsion method is achieved by adding the wall material and core material drop-
wise into an oil phase to form an emulsion, followed by hardening of the wall material 
with the addition of a gelling agent or a crosslinking agent (Champagne and Fustier 
2007). This method is costly because of the use of vegetable oil. Using this method, Sheu 
and Marshall (1993) developed a procedure to entrap L. bulgaricus by mixing it with 3% 
sodium alginate and suspending it into oil which contains 0.2% Tween 80. The particles 
produced protected the bacteria and improved survival in ice milk by 40% (Sheu and 
Marshall 1993) .  
 
In the emulsion method, the size of the particles is influenced by the speed of agitation 
and the type of emulsifier used. Smaller sized particles are desired for various reasons: 
They transport core material more efficiently, disperses better, and carry better 
mechanical strength (Chicheportiche and Reach 1988; Sugiura et al. 2005). The bead size 
achieved by the emulsion method varies from 25𝜇m to 2mm (Krasaekoopt et al. 2003). 
 
 
 
Capela et al. (2007) indicated that a bead size of 39.2𝜇m could be achieved by using a 
homogenizing speed of 13,500 rpm for 4 minutes. 
 
1.2.2 Extrusion method 
Extrusion is the simplest and most common technique for forming  hydrocolloid particles 
(King 1995).  The size of the particles obtained with the extrusion method (2-5mm) is 
larger than that obtained from the emulsion method (25µm- 2mm) (Sheu and Marshall 
1993; Sultana et al. 2000). In this process, the core material and alginate pass through a 
syringe needle and drop into the hardening solution (containing cations such as calcium). 
The particles are then formed immediately when the drop comes in contact with the 
hardening solution. The size of the particles is dependent on the size of the needle, and 
the distance between the needle and the hardening solution (de Vos et al. 2010; Gouin 
2004; Krasaekoopt et al. 2003). The advantage of the extrusion technology is that the 
wall material could be a shell over the core material, or the wall material and core 
material could be produced as a matrix (Gibbs et al. 1999). 
 
 
1.2.3 Other encapsulation methods 
Spray-drying is the most widely used and studied technology in the food industry for 
microencapsulation because of its suitability for economical large-scale industrial 
 
 
 
application (Dziezak 1988). The first spray-dryer was constructed in 1878 for 
pharmaceutical use (Hayashi 1989). The one-step continuous process and readily 
available equipment allows for easy operation and reproducibility. Encapsulation by this 
technology involves the atomization of an aqueous suspension into a drying gas, the 
water evaporates due to high temperature, then the dry particles could be collected 
(Tonon et al. 2011). The process is controlled by the feed rate, inlet and outlet 
temperature, and gas flow (Rokka and Rantamaki 2010). Spray drying was once 
considered an inferior method for encapsulating probiotics since the survival rate of the 
bacteria was low due to the dehydration and thermal inaction of the microorganism (Fu 
and Etzel 1995; Saarela et al. 2000). However, a relatively high survival rate of 
Bifidobacterium was reported when utilizing an inlet temperature of 100℃ and an outlet 
temperature of 45℃ with modified starch as wall material (O'Riordan et al. 2001). But 
the drawback of this modified method is that it affects the ability of the probiotics to 
resist the gastrointestinal environment (Del Piano et al. 2008). 
 
Spray chilling is similar to spray drying except that the atomized core material and wall 
material suspension are chilled by cooled air instead of heated air (Nazzaro et al. 2012). 
The cool air leads to solidification of the wall material around the core material since the 
melting point of the wall material is usually higher than the air temperature (Chambi et al. 
2008; Champagne and Fustier 2007; Pedroso et al. 2012).  The wall material is usually 
fractionated or hydrogenated vegetable oil which has a melting point ranging from 32-
 
 
 
42℃ (Risch 1995). Therefore, the release of the core material from the microsphere 
produced by this method can be controlled by the temperature. Frozen liquid, heat-
sensitive materials and water-insoluble materials can be used in this method (Gibbs et al. 
1999). Spray chilling is considered to be the cheapest encapsulation technique (Gouin 
2004). 
 
1.3 Wall material selection 
Various substances can be used as wall material to entrap, coat, or encapsulate. However, 
only a few of them are regarded as “generally recognized as safe” (GRAS) materials. 
Numerous encapsulation techniques are limited because of the lack of GRAS materials. 
Food regulations are stricter than the ones applied in the pharmacy industry when 
regarding wall material choice (Wandrey et al. 2010). Commonly used wall materials are 
alginate, starch, xanthan gum, cellulose, gelatin, chitosan and ƙ-carrageenan.  The choice 
of the wall material is dependent on the method adopted and the core material used.  
 
Ding and Shah (2009) tested the protection role of alginate, xanthan gum, and 
carrageenan gum when encapsulating Lactobacillus rhamnosus under acidic conditions 
over 8 hours of incubation. They found that the viability of the probiotics was reduced by 
3.63 log CFU/mL, respectively, compared to free cells which showed a reduction of 6 log 
CFU/mL.  
 
 
 
1.3.1 Alginate 
Alginates are naturaly occurring polysaccharides either extracted from seaweed or 
produced by bacteria (Gombotz and Wee 1998). The alginate molecule is a block 
copolymer composed of sequential M units (1,4-linked ß-D-mannuronic acid) and G unit 
(α-L-gluluronic acid), with the sequential distribution depending upon the source of the 
alginate (Martinsen et al. 1989). Divalent cations such as Ca
2+
 tend to bind to the G unit 
(Krasaekoopt et al. 2003), inducing ionic interchain bridges, which results in an egg-box 
structure in alginate gel (Rees 1981). Other divalent cations such as Pb
2+
, Co
2+
 and Ni
2+
 
are not used for food applications because of their toxicity. Alginate is the most used 
biopolymer for encapsulation (Saarela et al. 2000). The unique properties of alginate such 
as a high gel porosity and ease of processing at room temperature make it an ideal matrix 
material for encapsulation (Gombotz and Wee 1998).    
 
Various reports have indicated the success of using alginate as wall material alone or in 
combination with others. Alginate as wall material has been tested with concentrations 
ranging from 1% to 3%, along with 0.05-1.5M CaCl2 (Chandramouli et al. 2004; Cui et 
al. 2000; Kearney et al. 1990; Krasaekoopt et al. 2006; Prevost and Divies 1988; Sheu 
and Marshall 1993).  Jankowski et al. (1997) tested 0.6% sodium alginate with 0.05, 0.10, 
and 0.30 M CaCl2 and found out that the viability and fermentation ability of 
L.acidophilus during yogurt manufacture increased compared to unencapsulated bacteria.  
 
 
 
 
However, alginate is very sensitive to acid. It has been reported to degrade under acidic 
conditions because the cross-linking network suffers a reduction in molecular weight 
(Mumper et al. 1994). It is because the hydration links between the M and G units are 
broken. The network then becomes loose, which fastens the degradation of alginate 
(Gombotz and Wee 2012).  
 
An alginate gel is very porous, which usually requires another coating agent to enhance 
protection of the core material, especially in acidic conditions (Klein et al. 1983; 
Taqieddin and Amiji 2004). Higher than 5% of alginate is usually avoided because of 
handling difficulties during processing (Gombotz and Wee 2012). The low viscosity of 
the alginate solution lacks mechanical and physical stability (Peirone et al. 1998; 
Smidsrod and Skjakbraek 1990).  
 
1.3.2 Resistant starch type 4 
Starches are polysaccharides that are composed of a number of monosaccharides or sugar 
molecules linked with α-D-(1-4) or α-D-(1-6) linkages. It consists of amylose, which is a 
linear polymer of glucose with α-D-(1,4) linkages, and amylopectin, which is a branched 
molecule with α-D-(1-4) and α-D-(1-6) linkages (Sajilata et al. 2006). Resistant starch is 
defined as a small fraction of the starch, and starch degradation products that are resistant 
to digestion in the small intestine of healthy humans (Asp 1992). There are four types of 
 
 
 
resistant starch. Resistant starch type 1 (RS1) is a physically inaccessible starch trapped 
within whole grains or seeds. Resistant starch type 2 (RS2) is a high amylose granular 
starch from certain plants. Resistant starch type 3 (RS3) is retrograded starch after 
gelatinization, and the linearly/cross-linked starch that is difficult to hydrolyze by α-
amylose is called resistant starch type 4 (RS4) (Lee et al. 2007). The ability to resist 
digestion by pepsin and pancreatin-bile are found in 82% of RS4 (Lee et al. 2007). 
 
Starch has long been used as the wall material for encapsulation since the starch granule 
is an ideal surface for attachment of probiotic cells. Additionally, resistant starch can also 
offer the benefit of not being digested, which allows it to reach the colon where it is 
fermented (Kritchevsky 1995). Sultana et al. (2000) incorporated Hi-Maize starch into 
alginate and improved the viability of probiotics compared to encapsulation without 
starch. Resistant starch can also be used as an adherence surface for the probiotics during 
processing, storage and transit through the upper gastrointestinal tract (Anal and Singh 
2007).  
 
1.3.3 Potato starch 
Potato Starch consists of starch particles that are oval or spherical in shape with a 
diameter of 5-100 µm. The pasting temperature is around 60-65°C and it has very high 
 
 
 
pasting viscosity. The film strength, flexibility and solubility obtained with potato starch 
are very high, and provides solutions with high clarity (BeMiller 2009). 
 
The main purpose of using potato starch during encapsulation is to take advantage of its 
adherence capacity. Crittenden et al. (2001) investigated the adherent capacity of the 
Bifidobacterium strains to adhere to potato starch and a few other starches. They found 
that the binding capacity was related to the surface area of the granules and was not 
affected by bile salt. Based on their results, they have proposed the use of potato starch 
for encapsulation technology. 
 
The VTT Technical Research Center of Finland carried a study to encapsulate the lactic 
acid bacteria with potato starch. Large potato starch granules (50-100 µm) were 
enzymatically treated to obtain a porous structure and then used as carrier. During 
encapsulation, lactic acid bacteria adhere to the pores of the potato starch. With another 
coating of amylose, the lactic acid bacteria could survive at least 6 months at room 
temperature (Mattila-Sandholm et al. 2002).  
 
1.3.4 Other wall materials 
Chitosan is a linear polysaccharide essentially composed of ß (1-4) glucosamine units 
together with N-acetylglucosamine units to form a linear structure (Peniche et al. 2003). 
 
 
 
The cross-link network is formed in the presence of anions or polyanions (Burgain et al. 
2011). During encapsulation, it is preferably used as a second coating due to its low 
encapsulation efficiency (Mortazavian et al. 2008). Chitosan is commonly used along 
with alginate. Lee et al. (2004) tested the effect of three different chitosan coatings on 
alginate beads. They indicated that chitosan with high molecular weight showed higher 
survival of L. bulgaricus after exposure to simulated gastric and intestinal juice, 
compared to alginate alone as carrier. 
 
Gellan gum and xanthan gum are used in combination to form beads during 
encapsulation. Gellan gum is a microbial polysaccharide derived from Pseudomonas 
elodea(Jansson et al. 1983). It has a tetrasaccharide repeating unit consisting of two ß-D-
glucose, one ß-glururonic acid and one α-L-rhamnose residue (Grasdalen and Smidsrod 
1987). Xanthan gum is a heteropolysaccharide consisting of two glucose units, two 
mannose units, and one glucuronic acid unit (Garcia-Ochoa et al. 2000). Gellan gum and 
xanthan gum used together as carriers show high resistance to acidic environments 
compared to alginate. Sun and Griffiths (2000) indicated that the viability of the 
encapsulated bifidobacteria decreased only 0.67 log CFU/mL, while the free cells 
dropped from 1.23×10
9
 CFU/mL to an undetectable level after 30 minutes of incubation 
at pH 2.5.  
 
 
 
 
Ƙ-carrageenan is a natural polymer and is commonly used in the food industry (Burgain 
et al. 2011). The core material is added to a solution containing this polymer at 40-50°C. 
After the mixture is cooled down to room temperature, the gelation occurs. Particles are 
then stabilized by the addition of potassium ions (Krasaekoopt et al. 2003). Dinakar and 
Mistry (1994) indicated that the encapsulated Bifidobacterium bifidum maintained 
viability for as long as 24 weeks during cheddar cheese ripening. 
 
 
1.4 Probiotics 
Probiotics are defined as "live microbial supplements that beneficially affect the host by 
improving its intestinal microbial balance" (Fuller 1989). Health claims on probiotics 
include anti colon cancer properties, reduced risks of irritable bowel syndrome, and 
prevention of inflammatory bowel disease (Santosa et al. 2006; Wollowski et al. 2001). 
The probiotic effect mechanisms are attributed to the production of acid, or bacteriocins, 
reinforcement of body’s natural defense, and competition with pathogens (Krasaekoopt et 
al. 2003). The probiotics obtained from food sources must survive passage through the 
upper gastrointestinal (GI) tract and function in the gut environment to achieve the 
defined health benefits (Saarela et al. 2000).  
 
1.4.1 Lactobacillus acidophilus 
 
 
 
Lactic acid bacteria (LAB) are a group of bacteria that are gram-positive, non-
sporeforming, facultative aerobes, cocci or rods, which produce lactic acid as the major 
end product during the fermentation of carbohydrates (Sebastian et al. 2011). LAB used 
as probiotics prevent adherence, establishment, and replication of certain pathogens 
(Naidu et al. 1999). The main therapeutic and health benefits of L. acidophilus  are that 
they enhance the immune system, and prevent intestinal infections, diarrheal disease, 
colon cancer and upper gastrointestinal tract diseases (Kailasapathy and Chin 2000). It 
has been reported that certain isolated strains of Lactobacillus influence the metabolic 
activity of the resident microflora in the human gut (Lee and Salminen 1995).  Gilliland 
et al. (1985) reported that L. acidophilus had the ability to resist bile salt and decrease 
cholesterol levels. L. acidophilus is one of the most popular bacteria used as probiotics 
for human consumption (Amir Mortazavian 2007). In the United States, over 80% of the 
yoghurt in the market contains L. acidophilus (Gomes and Malcata 1999). However, 
Shah et al. (1995) indicated that L. acidophilus showed a constant decline in viable cells 
during storage in commercial yogurt.  
 
The viability of L. acidophilus showed a 6-log CFU/mL reduction after 2 hours of 
incubation at pH 2.0. It also has shown a reduction from 10.2-log CFU/mL to 6.3-log 
CFU/mL after 4 hours of exposure to bile salt (Ding and Shah 2007). Schillinger (1999) 
isolated L. acidophilus from novel-type probiotic dairy products, and found that four out 
of eight mild yogurt contained less than 10
4
 CFU/g at the end of storage (best before use 
 
 
 
day). Therefore, encapsulation may provide the protection needed to retain cell viability 
of probiotics, such as L. acidophilus, when incorporated them into food system, 
especially acidic foods. 
 
 
 
 
1.5 Encapsulation of probiotics 
The ability of beneficial microorganisms to survive GI transit and multiply in the host 
strongly influences their probiotic benefits. The bacteria should be metabolically stable 
and active in the product, survive passage through the upper digestive tract in large 
numbers, and have beneficial effects when in the intestine of the host (Gilliland 1989). 
Adequate numbers of viable cells are required to be consumed in order to transfer the 
probiotic effects to consumers. It is suggested that the product should contain at least 10
5 
active cells per gram of probiotics to provide the desired benefits (Kebary 1996). 
However, a low viability of probiotics in dairy products has been indicated by various 
reports (Gilliland and Speck 1977b; Klaver et al. 1993; Kneifel et al. 1993; Micanel et al. 
1997; Phillips et al. 2006; Rybka and Kailasapathy 1995; Schillinger 1999; Shah and 
Lankaputhra 1997). Vinderola et al. (2000) reported that the viability of Bifidobacterium 
 
 
 
and L. acidophilus in Argentinian yogurt were reduced by 1-4 log after 4 weeks of 
storage.   
 
Encapsulation, therefore, could provide probiotics with a barrier to resist adverse food 
environments, since it has been widely used to protect microorganisms from 
environmental and physiological degradation (Corbo et al. 2011; Lim and Moss 1981). It 
has been proven that encapsulation increased the viability of microorganisms in both 
dairy products and the intestinal tract by simulated digestion. Table 1.3 shows successful 
examples of probiotic encapsulation using different methods with the ultimate goal of 
applying them in yogurt. Lee and Heo (2000) found that the death rate of B. longum 
decreased proportionally with increased bead size and alginate concentration after 
exposure to simulated gastric juice and bile salt solution. Chavarri et al. (2010) also found 
that the encapsulated B. bifidum showed significantly decreased death rate after exposure 
to simulated gastric conditions (pH 2.0, 2h) and bile solution (3%, 2h) when compared 
with free cells.  
 
1.6 Release mechanism 
To determine viability in encapsulated material, bacteria cells need to be released from 
the beads. When the wall material contains alginate, the cross-linking network can be 
broken by the removal of cation ions (Ferreira Almeida and Almeida 2004). To achieve 
 
 
 
this, chelating agents such as ethylene glycol tetraacetic acid, lactate, citrate, phosphate or 
a high concentration of ions such as Na
+
 or Mg
2+
 can be used
 
(Gombotz and Wee 2012). 
Sheu and Marshall (1993) tested the effect of pH of phosphate buffer ranging from 4.8-
8.5 on the release of bacterial cells and found no significant differences among the pHs 
tested. They also found that the cells reached plateau at ten minute with phosphate buffer 
(0.05M, pH 4.8-8.5). Higher concentrations of phosphate buffer further shortens the 
release time to 5 minutes.  
 
 
1.7 Physicochemical characterization of microparticles 
1.7.1 Particle size distribution 
Laser diffraction is commonly used to determine the particle size of encapsulated 
materials since it is efficient and repeatable. This method also characterizes volume size 
distribution (Merkus 2009). Hyndman et al. (1993) tested the mean diameter of the 
microparticles after encapsulation of Lactococcus lactis in gelatin using a particle size 
analyzer. Brauss et al. (1999) determined the particle size of casein-fat droplets in yogurt 
using the same method to reveal the connection between fat content and flavor release. 
 
 
 
 
 
 
1.7.2 Morphology of microparticles 
It is important to study the morphology of microparticles to check the aggregation and 
damage on the surfaces of particles. When adopting the emulsion method, the 
morphology of the microparticles are easily affected by processing changes (speed of 
adding the calcium chloride, mixing speed, etc.) (Sheu and Marshall 1993). Optical and 
electron microscopy are widely used to observe the size and shape of particles that are 0.2 
µm or larger. Scanning electronic microscopy (SEM) is commonly used to study the 
surface morphology, such as pores and internal structures by viewing cross-sections of 
the beads (Zhang et al. 2010).   
 
 
1.8 Objectives 
Microencapsulation technology has been extensively used since its first appearance, with 
the most well-developed techniques being used by the pharmaceutical industry. In the 
food industry, research is now focusing on flavor delivery, while the area of 
encapsulating functional ingredients, which is a huge market, is still waiting for 
expansion. Probiotics as a functional ingredient has attracted much attention with recent 
consumer trends that promote consumption of more natural and beneficial diets. 
Therefore, there is a good opportunity to explore new encapsulation approaches of 
probiotics. Some fundamental research on encapsulation of L. acidophilus encapsulation 
has been accomplished; however, survival is normally low and inconsistent, and 
 
 
 
applications in food systems are not well-studied. Therefore, the goal of this research is to 
encapsulate Lactobacillus acidophilus DDS 1-10 in food grade wall material with both 
emulsion and extrusion method, to increase the survivability of the probiotics and to 
incorporate them into food systems. 
 
The specific objectives are to: 
1. Select the best alginate-starch mixture/composition to encapsulate Lactobacillus 
acidophilus DDS 1-10. 
2. Optimize processing conditions to prepare encapsulated probiotics with maximum 
encapsulation efficiency with both emulsion and extrusion methods. 
3. Evaluate and maximize the viability of the encapsulated cells. 
4. Verify the stability of particles in selected conditions (pH, bile salt, and 
temperature) with particles obtained from both emulsion and extrusion methods. 
5. Incorporate the particles obtained from both emulsion and extrusion method and 
investigate their behavior during storage. 
 
 
 
 
 
 
 
1.9 References 
Amir Mortazavian, S. H. R., Mohammad Reza Ehsani. 2007. Principles and methods of 
microencapsulation of probiotic microorganisms. Iranian Journal of 
Biotechnology 5. 
Anal, A. K. and Singh, H. 2007. Recent advances in microencapsulation of probiotics for 
industrial applications and targeted delivery. Trends in Food Science & 
Technology 18:240-251. 
Asp, N. G. 1992. Resistant Starch - Proceedings from the 2nd Plenary Meeting of Euresta 
- European Flair Concerted Action 11 on Physiological Implications of the 
Consumption of Resistant Starch in Man. European Journal of Clinical Nutrition 
46:S1-S1. 
Augustin, M. A., Sanguansri, L., Margetts, C. and Young, B. 2001. Microencapsulation 
of food ingredients. Food Australia 53:220-223. 
BeMiller, J. N. 2009. Starch: Chemistry and Technology Third Edition Preface to the 
Third Edition. Starch: Chemistry and Technology, 3rd Edition:Xvii-Xviii. 
Brauss, M. S., Linforth, R. S. T., Cayeux, I., Harvey, B. and Taylor, A. J. 1999. Altering 
the fat content affects flavor release in a model yogurt system. J Agric Food 
Chem 47:2055-2059. 
Burgain, J., Gaiani, C., Linder, M. and Scher, J. 2011. Encapsulation of probiotic living 
cells: From laboratory scale to industrial applications. Journal of Food 
Engineering 104:467-483. 
Capela, P., Hay, T. K. C. and Shah, N. P. 2007. Effect of homogenisation on bead size 
and survival of encapsulated probiotic bacteria. Food Research International 
40:1261-1269. 
Chambi, H. N. M., Alvim, I. D., Barrera-Arellano, D. and Grosso, C. R. F. 2008. Solid 
lipid microparticles containing water-soluble compounds of different molecular 
mass: Production, characterisation and release profiles. Food Research 
International 41:229-236. 
Champagne, C. P. and Fustier, P. 2007. Microencapsulation for the improved delivery of 
bioactive compounds into foods. Current Opinion in Biotechnology 18:184-190. 
Chandramouli, V., Kailasapathy, K., Peiris, P. and Jones, M. 2004. An improved method 
of microencapsulation and its evaluation to protect Lactobacillus spp. in 
simulated gastric conditions. Journal of Microbiological Methods 56:27-35. 
Chavarri, M., Maranon, I., Ares, R., Ibanez, F. C., Marzo, F. and Villaran, M. D. 2010. 
Microencapsulation of a probiotic and prebiotic in alginate-chitosan capsules 
improves survival in simulated gastro-intestinal conditions. Int J Food Microbiol 
142:185-189. 
Chicheportiche, D. and Reach, G. 1988. In vitro kinetics of insulin release by 
microencapsulated rat islets: effect of the size of the microcapsules. Diabetologia 
31:54-7. 
Corbo, M. R., Bevilacqua, A. and Sinigaglia, M. 2011. Shelf life of alginate beads 
containing lactobacilli and bifidobacteria: characterisation of microspheres 
 
 
 
containing Lactobacillus delbrueckii subsp bulgaricus. International Journal of 
Food Science and Technology 46:2212-2217. 
Crittenden, R., Laitila, A., Forssell, P., Matto, J., Saarela, M., Mattila-Sandholm, T. and 
Myllarinen, P. 2001. Adhesion of bifidobacteria to granular starch and its 
implications in probiotic technologies. Appl Environ Microbiol 67:3469-3475. 
Cui, J. H., Goh, J. S., Kim, P. H., Choi, S. H. and Lee, B. J. 2000. Survival and stability 
of bifidobacteria loaded in alginate poly-l-lysine microparticles. International 
Journal of Pharmaceutics 210:51-59. 
de Vos, P., Faas, M. M., Spasojevic, M. and Sikkema, J. 2010. Encapsulation for 
preservation of functionality and targeted delivery of bioactive food components. 
International Dairy Journal 20:292-302. 
Del Piano, M., Strozzi, P., Barba, M., Allesina, S., Deidda, F., Lorenzini, P., Morelli, L., 
Carmagnola, S., Pagliarulo, M., Balzarini, M., Ballare, M., Orsello, M., Montino, 
F., Sartori, M., Garello, E. and Capurso, L. 2008. In vitro sensitivity of probiotics 
to human pancreatic juice. Journal of Clinical Gastroenterology 42:S170-S173. 
Desai, K. G. H. and Park, H. J. 2005. Recent developments in microencapsulation of food 
ingredients. Drying Technology 23:1361-1394. 
Dinakar, P. and Mistry, V. V. 1994. Growth and Viability of Bifidobacterium-Bifidum in 
Cheddar Cheese. Journal of Dairy Science 77:2854-2864. 
Ding, W. K. and Shah, N. P. 2007. Acid, bile, and heat tolerance of free and 
microencapsulated probiotic bacteria. J Food Sci 72:M446-M450. 
Ding, W. K. and Shah, N. P. 2009. Effect of Various Encapsulating Materials on the 
Stability of Probiotic Bacteria. J Food Sci 74:M100-M107. 
Dziezak, J. D. 1988. Microencapsulation and Encapsulated Ingredients. Food Technology 
42:136-&. 
Fu, W. Y. and Etzel, M. R. 1995. Spray-Drying of Lactococcus-Lactis Ssp Lactis C2 and 
Cellular Injury. J Food Sci 60:195-200. 
Fuller, R. 1989. Probiotics in Man and Animals. Journal of Applied Bacteriology 66:365-
378. 
Garcia-Ochoa, F., Santos, V. E., Casas, J. A. and Gomez, E. 2000. Xanthan gum: 
production, recovery, and properties. Biotechnol Adv 18:549-579. 
Gibbs, B. F., Kermasha, S., Alli, I. and Mulligan, C. N. 1999. Encapsulation in the food 
industry: a review. Int J Food Sci Nutr 50:213-224. 
Gilliland, S. E. 1989. Acidophilus Milk-Products - a Review of Potential Benefits to 
Consumers. Journal of Dairy Science 72:2483-2495. 
Gilliland, S. E., Nelson, C. R. and Maxwell, C. 1985. Assimilation of cholesterol by 
Lactobacillus acidophilus. Appl Environ Microbiol 49:377-81. 
Gilliland, S. E. and Speck, M. L. 1977. Instability of Lactobacillus-Acidophilus in Yogurt. 
Journal of Dairy Science 60:1394-1398. 
Gombotz, W. R. and Wee, S. F. 1998. Protein release from alginate matrices. Advanced 
Drug Delivery Reviews 31:267-285. 
Gombotz, W. R. and Wee, S. F. 2012. Protein release from alginate matrices. Advanced 
Drug Delivery Reviews 64:194-205. 
 
 
 
Gomes, A. M. P. and Malcata, F. X. 1999. Bifidobacterium spp. and Lactobacillus 
acidophilus: biological, biochemical, technological and therapeutical properties 
relevant for use as probiotics. Trends in Food Science & Technology 10:139-157. 
Gouin, S. 2004. Microencapsulation: industrial appraisal of existing technologies and 
trends. Trends in Food Science & Technology 15:330-347. 
Grasdalen, H. and Smidsrod, O. 1987. Gelation of Gellan Gum. Carbohydrate Polymers 
7:371-393. 
Hayashi, H. 1989. Drying Technologies of Foods - Their History and Future. Drying 
Technology 7:315-369. 
Hyndman, C. L., Groboillot, A. F., Poncelet, D., Champagne, C. P. and Neufeld, R. J. 
1993. Microencapsulation of Lactococcus-Lactis within Cross-Linked Gelatin 
Membranes. Journal of Chemical Technology and Biotechnology 56:259-263. 
Jankowski, T., Zielinska, M. and Wysakowska, A. 1997. Encapsulation of lactic acid 
bacteria with alginate/starch capsules. Biotechnology Techniques 11:31-34. 
Kailasapathy, K. and Chin, J. 2000. Survival and therapeutic potential of probiotic 
organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. 
Immunology and Cell Biology 78:80-88. 
Kearney, L., Upton, M. and Mcloughlin, A. 1990. Enhancing the Viability of 
Lactobacillus-Plantarum Inoculum by Immobilizing the Cells in Calcium-
Alginate Beads Incorporating Cryoprotectants. Appl Environ Microbiol 56:3112-
3116. 
Kebary, K. M. K. 1996. Viability of Bifidobacterium bifidum and its effect on quality of 
frozen Zabady. Food Research International 29:431-437. 
King, A. H. 1995. Encapsulation of Food Ingredients - a Review of Available 
Technology, Focusing on Hydrocolloids. Encapsulation and Controlled Release of 
Food Ingredients 590:26-39. 
Klaver, F. A. M., Kingma, F. and Weerkamp, A. H. 1993. Growth and Survival of 
Bifidobacteria in Milk. Netherlands Milk and Dairy Journal 47:151-164. 
Klein, J., Stock, J. and Vorlop, K. D. 1983. Pore-Size and Properties of Spherical Ca-
Alginate Biocatalysts. European Journal of Applied Microbiology and 
Biotechnology 18:86-91. 
Kneifel, W., Jaros, D. and Erhard, F. 1993. Microflora and Acidification Properties of 
Yogurt and Yogurt-Related Products Fermented with Commercially Available 
Starter Cultures. Int J Food Microbiol 18:179-189. 
Krasaekoopt, W., Bhandari, B. and Deeth, H. 2003. Evaluation of encapsulation 
techniques of probiotics for yoghurt. International Dairy Journal 13:3-13. 
Krasaekoopt, W., Bhandari, B. and Deeth, H. 2004. The influence of coating materials on 
some properties of alginate beads and survivability of microencapsulated 
probiotic bacteria. International Dairy Journal 14:737-743. 
Krasaekoopt, W., Bhandari, B. and Deeth, H. C. 2006. Survival of probiotics 
encapsulated in chitosan-coated alginate beads in yoghurt from UHT- and 
conventionally treated milk during storage. Lwt-Food Science and Technology 
39:177-183. 
 
 
 
Kritchevsky, D. 1995. Epidemiology of Fiber, Resistant Starch and Colorectal-Cancer. 
European Journal of Cancer Prevention 4:345-352. 
Leblond, F. A., Simard, G., Henley, N., Rocheleau, B., Huet, P. M. and Halle, J. P. 1999. 
Studies on smaller (similar to 315 mu M) microcapsules: IV. Feasibility and 
safety of intrahepatic implantations of small alginate poly-L-lysine microcapsules. 
Cell Transplant 8:327-337. 
Lee, J. S., Cha, D. S. and Park, H. J. 2004. Survival of freeze-dried Lactobacillus 
bulgaricus KFRI 673 in chitosan-coated calcium alginate microparticles. J Agric 
Food Chem 52:7300-7305. 
Lee, K. Y. and Heo, T. R. 2000. Survival of Bifidobacterium longum immobilized in 
calcium alginate beads in simulated gastric juices and bile salt solution. Appl 
Environ Microbiol 66:869-873. 
Lee, W. J., Youn, Y. N., Yun, Y. H. and Yoon, S. D. 2007. Physical properties of 
chemically modified starch(RS4)/PVA blend films- Part 1. Journal of Polymers 
and the Environment 15:35-42. 
Lee, Y. K. and Salminen, S. 1995. The Coming of Age of Probiotics. Trends in Food 
Science & Technology 6:241-245. 
Lim, F. and Moss, R. D. 1981. Microencapsulation of Living Cells and Tissues. Journal 
of Pharmaceutical Sciences 70:351-354. 
Martinsen, A., Skjakbraek, G. and Smidsrod, O. 1989. Alginate as Immobilization 
Material .1. Correlation between Chemical and Physical-Properties of Alginate 
Gel Beads. Biotechnology and Bioengineering 33:79-89. 
Mattila-Sandholm, T., Myllarinen, P., Crittenden, R., Mogensen, G., Fonden, R. and 
Saarela, M. 2002. Technological challenges for future probiotic foods. 
International Dairy Journal 12:173-182. 
Merkus, H. G. 2009. Particle Size Measurements Fundamentals, Practice, Quality 
Introduction. Particle Size Measurements: Fundamentals, Practice, Quality 17:1-
11. 
Micanel, N., Haynes, I. N. and Playne, M. J. 1997. Viability of probiotic cultures in 
commercial Australian yogurts. Australian Journal of Dairy Technology 52:24-27. 
Mortazavian, A. M., Aziz, A., Ehsani, M. R., Razavi, S. H., Mousavi, S. M., Sohrabvandi, 
S. and Reinheimer, J. A. 2008. Survival of encapsulated probiotic bacteria in 
Iranian yogurt drink (Doogh) after the product exposure to simulated 
gastrointestinal conditions. Milchwissenschaft-Milk Science International 63:427-
429. 
Naidu, A. S., Bidlack, W. R. and Clemens, R. A. 1999. Probiotic spectra of lactic acid 
bacteria (LAB). Critical Reviews in Food Science and Nutrition 39:13-126. 
Nakazawa, Y., Kamijo, Y., Fujimoto, K., Kawaguchi, H., Yuguchi, Y., Urakawa, H. and 
Kajiwara, K. 1996. Preparation and structural characteristics of stimuli-responsive 
hydrogel microsphere. Angewandte Makromolekulare Chemie 240:187-196. 
O'Riordan, K., Andrews, D., Buckle, K. and Conway, P. 2001. Evaluation of 
microencapsulation of a Bifidobacterium strain with starch as an approach to 
prolonging viability during storage. J Appl Microbiol 91:1059-1066. 
 
 
 
Pedroso, D. D., Thomazini, M., Heinemann, R. J. B. and Favaro-Trindade, C. S. 2012. 
Protection of Bifidobacterium lactis and Lactobacillus acidophilus by 
microencapsulation using spray-chilling. International Dairy Journal 26:127-132. 
Peirone, M., Ross, C. J. D., Hortelano, G., Brash, J. L. and Chang, P. L. 1998. 
Encapsulation of various recombinant mammalian cell types in different alginate 
microcapsules. Journal of Biomedical Materials Research 42:587-596. 
Phillips, M., Kailasapathy, K. and Tran, L. 2006. Viability of commercial probiotic 
cultures (L. acidophilus, Bifidobacterium sp., L. casei, L. paracasei and L. 
rhamnosus) in cheddar cheese. Int J Food Microbiol 108:276-280. 
Prevost, H. and Divies, C. 1988. Continuous Pre-Fermentation of Milk by Entrapped 
Yogurt Bacteria .2. Data for Optimization of the Process. Milchwissenschaft-Milk 
Science International 43:716-719. 
Rees, D. A. 1981. Polysaccharide Shapes and Their Interactions - Some Recent Advances. 
Pure and Applied Chemistry 53:1-14. 
Risch, S. J. 1995. Encapsulation - Overview of Uses and Techniques. Encapsulation and 
Controlled Release of Food Ingredients 590:2-7. 
Rokka, S. and Rantamaki, P. 2010. Protecting probiotic bacteria by microencapsulation: 
challenges for industrial applications. European Food Research and Technology 
231:1-12. 
Rybka, S. and Kailasapathy, K. 1995. The Survival of Culture Bacteria in Fresh and 
Freeze-Dried Ab Yogurts. Australian Journal of Dairy Technology 50:51-57. 
Saarela, M., Mogensen, G., Fonden, R., Matto, J. and Mattila-Sandholm, T. 2000. 
Probiotic bacteria: safety, functional and technological properties. J Biotechnol 
84:197-215. 
Sajilata, M. G., Singhal, R. S. and Kulkarni, P. R. 2006. Resistant starch - A review. 
Comprehensive Reviews in Food Science and Food Safety 5:1-17. 
Santosa, S., Farnworth, E. and Jones, P. J. H. 2006. Probiotics and their potential health 
claims. Nutrition Reviews 64:265-274. 
Schillinger, U. 1999. Isolation and identification of lactobacilli from novel-type probiotic 
and mild yoghurts and their stability during refrigerated storage. Int J Food 
Microbiol 47:79-87. 
Sebastian, P., Herr, P., Fischer, U. and Konig, H. 2011. Molecular Identification of Lactic 
Acid Bacteria Occurring in Must and Wine. South African Journal of Enology 
and Viticulture 32:300-309. 
Shah, N. P. and Lankaputhra, W. E. V. 1997. Improving viability of Lactobacillus 
acidophilus and Bifidobacterium spp. in yogurt. International Dairy Journal 
7:349-356. 
Shah, N. P., Lankaputhra, W. E. V., Britz, M. L. and Kyle, W. S. A. 1995. Survival of 
Lactobacillus-Acidophilus and Bifidobacterium-Bifidum in Commercial Yogurt 
during Refrigerated Storage. International Dairy Journal 5:515-521. 
Shahidi, F. and Han, X. Q. 1993. Encapsulation of Food Ingredients. Critical Reviews in 
Food Science and Nutrition 33:501-547. 
Sheu, T. Y. and Marshall, R. T. 1993. Microentrapment of Lactobacilli in Calcium 
Alginate Gels. J Food Sci 58:557-561. 
 
 
 
Singer, N. S. and Dunn, J. M. 1990. Protein Microparticulation - the Principle and the 
Process. J Am Coll Nutr 9:388-397. 
Smidsrod, O. and Skjakbraek, G. 1990. Alginate as Immobilization Matrix for Cells. 
Trends in Biotechnology 8:71-78. 
Solanki, H. K., Pawar, D. D., Shah, D. A., Prajapati, V. D., Jani, G. K., Mulla, A. M. and 
Thakar, P. M. 2013. Development of microencapsulation delivery system for 
long-term preservation of probiotics as biotherapeutics agent. Biomed Res Int 
2013:620719. 
Sugiura, S., Oda, T., Izumida, Y., Aoyagi, Y., Satake, M., Ochiai, A., Ohkohchi, N. and 
Nakajima, M. 2005. Size control of calcium alginate beads containing living cells 
using micro-nozzle array. Biomaterials 26:3327-3331. 
Sultana, K., Godward, G., Reynolds, N., Arumugaswamy, R., Peiris, P. and Kailasapathy, 
K. 2000. Encapsulation of probiotic bacteria with alginate-starch and evaluation 
of survival in simulated gastrointestinal conditions and in yoghurt. Int J Food 
Microbiol 62:47-55. 
Sun, W. R. and Griffiths, M. W. 2000. Survival of bifidobacteria in yogurt and simulated 
gastric juice following immobilization in gellan-xanthan beads. Int J Food 
Microbiol 61:17-25. 
Taqieddin, E. and Amiji, M. 2004. Enzyme immobilization in novel alginate-chitosan 
core-shell microcapsules. Biomaterials 25:1937-1945. 
Vinderola, C. G., Bailo, N. and Reinhemier, J. A. 2000. Survival of probiotic microflora 
in Argentinian yoghurts during refrigerated storage. Food Research International 
33:97-102. 
Wandrey, C., Bartkowiak, A. and Harding, S. E. 2010. Materials for Encapsulation. 
Encapsulation Technologies for Active Food Ingredients and Food Processing:31-
100. 
White, M. A. 1998. The chemistry behind carbonless copy paper. Journal of Chemical 
Education 75:1119-1120. 
Wollowski, I., Rechkemmer, G. and Pool-Zobel, B. L. 2001. Protective role of probiotics 
and prebiotics in colon cancer. American Journal of Clinical Nutrition 73:451s-
455s. 
Zhang, Z. B., Law, D. and Lian, G. P. 2010. Characterization Methods of Encapsulates. 
Encapsulation Technologies for Active Food Ingredients and Food 
Processing:101-125. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1.1 Comparison of microencapsulation techniques 
Technique Advantage Disadvantage Reference 
Emulsion Easy to scale up 
Mild process 
Non-uniform particle size 
Expensive 
(Krasaekoopt et al. 2003) 
Spray drying Economical 
Well developed 
Limited wall materials  
High temperature 
(Gouin 2004) 
Spray chilling Temperature controlled 
Inexpensive 
Fat as wall material 
Special storage condition 
(Pedroso et al. 2012) 
Extrusion Simple process 
Uniform particle size 
Difficult to scale up 
Limited wall materials 
(Gouin 2004) 
 
 
 
 
 
Table 1.2 Major steps for encapsulation technique 
Technique Major process 
Emulsion 1.  Cell is dispersed in the wall material 
2.  Mixture is added dropwidse into oil to form emulsion 
3.  Mixture is then solidified to form particles 
Spray 
drying 
1. Preparation of the wall material solutions with cells  
2. Atomization of the mixture into spray 
3. Drying of the spray 
4. Separation of the dry particles 
Extrusion 1.  Preparation of wall material solution with cells 
2.  Extrusion of the mixture through syringe into the hardening solution 
3.  Formation of the particles 
Spray 
chilling 
1. Preparation of the wall material solutions with cells  
2. Contact with cooled air 
3. Solidification of the particles 
4. Separation of the dry particles 
 
 
Table 1.3 applications of encapsulating probiotics on yogurt with different techniques 
Technique Wall material Core material Reference 
Emulsion Ƙ-carrageenan B. longum (Adhikari et al. 2003) 
Spray drying 85% milk fat 
5-15% whey protein 
B. breve (Picot and Lacroix 2004) 
Extrusion 2% sodium alginate L. acidophilus Krasaekoopt et al. (2006) 
Spray chilling Palm oil L.acidophilus (Pedroso et al. 2012) 
 
 
 
Chapter 2 Materials and methods 
2.1 L. acidophilus 
All the glassware and solutions used for the experiments were autoclaved at 121° C for 
15 min. The probiotic strain Lactobacillus acidophilus DDS 1-10 (L. acidophilus) was 
obtained from a commercial probiotic supplier (Nebraska Cultures, Walnut creek, CA). 
From a frozen stock culture, an aliquot of 100 μL L. acidophilus was streaked on De Man 
Rogosa Sharp agar (MRS, Acumedia, Neogen Corporation, Lansing, MI). Plates were 
then incubated anaerobically (Mitsubishi, Tokyo, Japan) for 24 hours at 37°C. Gram stain 
was then performed on single colonies. Colonies with the expected morphology were 
transferred and grown overnight at 37 °C in MRS broth (Acumedia, Neogen Corporation, 
Lansing, MI). Sterile glycerol (7%, v/v) was added to the broth and 1 mL aliquots were 
stored at -80 °C for future use.  
 
 
2.2 Preparation of cell suspension 
 Cultures used for encapsulation were grown for 24 hours by adding 100 μL of a stock 
culture of L. acidophilus stock culture into 9 mL MRS broth and incubating at 37°C 
anaerobically. They were then transferred to 500 mL MRS broth and incubated for 48 
hours at 37°C anaerobically. The optical density of MRS broth (with cells) were 
measured at 650 nm using a Spectronic 20D+ spectrophotometer (Spectronic 
 
 
 
Instruments, Thermo Fisher Scientific, Waltham, MA), with MRS broth (without cells) 
as a blank. Based on the reading, the volume of the MRS broth (with cells) used were 
determined by comparison with growth curves previously obtained for L. acidophilus 
(Figure 2.1). Cell pellets were then harvested using a Sorvall Legend XTR centrifuge 
(Thermo Scientific, Hampton, NH) at 2780×g for 8 minutes. Cell pellets were washed 
with sterile water twice and decanted under the same centrifugation conditions. The cell 
pellets were then resuspended in 10 mL phosphate buffer solution (PBS) to obtain a final 
cell counts of 6×10
8
 CFU/mL.  
    
 
2.3 Preparation of encapsulation matrix 
Sodium alginate (Kimica Corp., Chuo-Ku, TY, Japan) of grade IL-1, potato starch 
(Penford Food Ingredients Company, Centennial, CO), and type 4 resistant starch (RS4) 
(Fibersym
® 
RW, MGP Ingredients, Atchison, KS) were obtained from commercial 
sources. Different combinations of matrix materials were tested. The total solid content 
for all combinations was always maintained at 5% (w/v). Within this 5%, alginate content 
ranged from 1.6% to 4.4% (w/v), and the ratio of potato starch and RS4 was fixed at 2:1. 
All the combinations were displayed in Table 2.1. Thermal properties of potato starch 
and RS4 were measured using differential scanning calorimetry (DSC). Based on the 
thermal data, the mixture was heated to 85° C in preparation for use. 
 
 
 
 
2.4 Preparation of particles using the emulsion method 
The cell suspension was first mixed well with encapsulating material (1:5). The mixture 
was then pumped through a rubber tube into Hyvee soybean oil (Hyvee Inc., West Des 
Moines, IA) using a 101U/R pump (Watson-Marlow, Wilmington, MA) at 1.5 mL/min. 
A gauge-15 needle was connected at the end of the tube to drip the mixture into 250 mL 
soybean oil containing Tween 80 (0.2%, v/v) (Fisher Scientific, Hampton, NH) which 
was stirred at 450 rpm by a magnetic stirrer. A water/oil emulsion was formed. 
 
After the dripping was completed, 10 parts of calcium chloride (0.1M) (Aldrich Chemical 
Company Inc., St. Louis, MO) was added along the side of the beaker to the emulsion 
fast but gently (>20 mL/s) thus breaking the water/oil emulsion. The mixture was agitated 
for 30 min to allow the particles to form. After the mixing was finished, the mixture was 
left to stand for 60 min. During this period, phase separation occurred as the particles 
with encapsulated L. acidophilus started to precipitate and fall to the bottom. 
 
To collect the particles, the oil phase at the top was drained and the clear solution at the 
bottom was centrifuged (350g×g, 15 min). The particles were washed twice with sterile 
water and decanted under the same centrifugation conditions and then collected for use. 
The picture of the particles observed under microscopy is shown in Figure 2.2 
 
 
 
 
 
2.5 Preparation of particles using extrusion method 
The encapsulation matrix material and the cell suspension mixture (1:5) was pumped in 
the same way as described for the emulsion method using a needle (gauge 25) directly 
into calcium chloride (0.1M), which was stirred at 200 rpm by a magnetic stirrer. The 
distance between the needle and the calcium chloride solution was fixed at 3cm. Particles 
were immediately formed when the mixture came in contact with the calcium chloride 
solution. The solution was left to mix for 30 to 120 min to allow for the hardening of the 
particles. The particles were then collected by filtration using cheesecloth which was 
sterilized in boiling water for 12 min ahead of use. The particles were then washed with 
sterile water and collected for the following tests. The picture of the particles observed is 
shown in Figure 2.3. 
 
2.6 Analysis of physical properties of particles 
Particle size analysis of the particles from emulsion method was performed using a 
Malvern Mastersizer 3000 laser diffraction particle size analyzer, equipped with a Hydro 
MV wet dispersion unit (Malvern instruments Ltd., Malvern, Worcestershire, UK). 
Analytical parameters were set per the manufacturer’s database as follows: refractive 
index of 1.0, density of 1.0 g/cm
3
,
 
mixing speed of 2300 rpm, feed rate of 50%, and 
absorption index of 0.10. The particles were added into the wet dispersion cell until the 
obscuration reading became steady (within the limit of 0.1-20%). Data was analyzed 
using Malvern software (Version 2.20, Malvern instrument Ltd., Malvern, UK). 
 
 
 
 
The size of the particles from extrusion method was measured using a caliper (Mitutoyo, 
Aurora, IL). A single particle was placed between the jaws of the calipers to measure its 
diameter. Measurements were performed in triplicate. 
 
2.7 Release and enumeration of the encapsulated cells 
Encapsulated cells were released from the particles before enumerating. For the particles 
obtained with the emulsion method, 1 g of particles were added into 9 mL of potassium 
phosphate buffer (0.1M, pH 7.0). Then it was macerated using a tissue homogenizer. For 
the particles obtained with the extrusion method, 1 g of particles were added into a 
stomacher bag with 9 mL of potassium phosphate buffer (0.1M, pH 7.0). It was then 
blended in stomacher 400 (Seward, UK) gently for 10 min. An aliquot of 1 mL of the 
suspension obtained from both methods was serialy diluted for plating. Released cells 
were enumerated by spreading 100 µL of the diluted suspension into MRS plates and 
incubating for 48 hours at 37°C anaerobically. 
 
2.8 Optimization of encapsulation matrix material composition  
The optimum matrix material composition was determined by comparing the cell 
survivability of encapsulated cells with free cells after incubation in pH 2.0 MRS broth at 
37°C for 3 hours. MRS broth was adjusted to pH 2.0 using 3.0 M hydrochloric acid 
(Sigma Aldrich, St. Louis, MO). An aliquot of 9 mL of adjusted broths were added into 
 
 
 
sterile 15 mL centrifuge tubes. Either 1 g of encapsulated particles or 1 mL of washed 
cell suspension were added into the prepared tubes tempered at 37°C and vortexed for 
complete dispersion. The tubes were then incubated at 37°C. One tube was immediately 
sampled, and then another one after 3 hours for cell enumeration. The samplings were 
performed in triplicate.  
 
The harvesting of the particles from the emulsion method, or the extrusion method, and 
free cells used in this experiment were performed as follows. As already mentioned, to 
harvest the particles from the emulsion method, each tube was centrifuged (350×g, 8 
min), the supernatant decanted, and the remaining pellets washed with sterile water twice 
with water removed under the same centrifugation conditions. For the particles from the 
extrusion method, they were harvested by filtration using cheesecloth and washed with 
sterile water. To harvest the 48 hour cultured free cells, each tube was centrifuged 
(2780×g, 8 min), the supernatant poured out, and the remaining pellet washed twice with 
sterile water. 
 
At time zero and after incubation time, all enumerations were performed as described 
under section 2.7, for encapsulated cells. The tubes with free cells were centrifuged 
(2780×g, 8 min) to recover a pellet that was resuspended in 1 mL of PBS. Aliquots of 0.1 
mL were then used for serial dilutions. Viable counts were enumerated by spread plating 
on MRS agar after anaerobic incubation for 48 hours at 37°C. 
 
 
 
 
2.9 Acid and bile salt resistance of optimized particles 
Particles produced by the emulsion and the extrusion method using the optimum 
composition of the encapsulation matrix material were tested for acid and bile salt 
resistance and compared to the survivability of  free cells. MRS broth without addition of 
acid or bile salt was used as a control. For the treatments, MRS broth was adjusted to pH 
of 2.0, 4.0, and 7.0 using 3.0 M hydrochloric acid, and 0.5, 1, and 2% bile salt (Sigma 
Aldrich, St. Louis, MO). The adjusted broths were added into sterile 15 mL centrifuge 
tubes in 9-mL aliquots. Either 1 g of encapsulated particles or 1 mL of washed cell 
suspension were added into the prepared tubes tempered at 37°C and vortexed for 
complete dispersion. The tubes were then incubated at 37°C. One tube was immediately 
sampled, and then another at 6, 15, and 24 h for a total of four tubes. During each time 
point, all tubes, sampled or not sampled, were shaken gently. The samplings were 
performed in triplicates and enumeration of viable cells was performed using the same 
procedures described in Sections 2.7 and 2.8. 
  
 
 
 
 
 
 
 
 
2.10 Resistance of optimized particles to temperature  
Particles produced by the emulsion and the extrusion method using the optimized 
encapsulation material were tested for their viability at 25, 37, and 50°C and compared to 
free cells. Either 1 g of encapsulated particles or 1mL of L. acidophilus suspension were 
added into tubes containing 9 mL of MRS broth. The tubes were incubated at 25, 37, and 
50°C for 24 hours. Samplings were performed initially and after 24 hours using the same 
harvest, release and plating procedures described in Sections 2.7 and 2.8. 
 
2.11 Survivability test of optimized particles  
Based on results obtained with the pH experiments, the hardening time of the extrusion 
method was determined to be 120 min. Particles produced with the optimized 
composition for encapsulation using the extrusion method were tested under different 
conditions for a week. MRS broth without addition of acid was used as control. Tubes 
with 9 mL MRS broth adjusted to pH of 4.0, 4.5, and 5.0 using 3.0 M hydrochloric acid 
were also prepared. Each tube was added with 1 g of encapsulated particles. Enough 
tubes were prepared to allow the removal of one tube for each pH at each sampling time. 
Samplings were performed initially and then daily, for 7 days at 7 and 25°C, in triplicate. 
Encapsulated cells were enumerated as described in sections 2.7 and 2.8 on MRS plates 
after incubation anaerobically for 48 hours at 37°C. The limit of detection of the method 
was <100 CFU. 
 
 
 
 
2.12 Shelf life test of optimized particles 
Commercial products tested were Hyvee 2% reduced milk (Hyvee, West Des Moines, 
IA), V8 acai juice (Campbell’s Camden, NJ). They were pasteurized in 80°C water bath 
for 12 minutes to kill all the vegetative cells present in the products. They were then put 
into ice for cooling down.  Particles produced using the optimized matrix composition 
from the extrusion method were added to the pasteurized products (1 gram/10 mL). 
Samplings were performed initially and then after 4, 8, 12, 16 days. Encapsulated cells 
were enumerated as described in sections 2.7 and 2.8 on MRS plates after incubation 
anaerobically for 48 hours at 37°C. 
 
2.13 Statistical analysis 
This study was performed using a completely random design (CRD). Analysis of 
variance and mean differences were analyzed using SAS 9.4 (SAS Inc., Cary, NC) and 
JMP 10.0.0 (SAS Institute Inc., Cary, NC). All tests were conducted at a 5% level of 
significance. 
 
 
 
 
               
 
 
 
Table 2.1. Selected compositions of encapsulating material used for the extrusion and 
enumeration methods. 
Alginate(%,w/v) Potato starch: RS4 Ratio 
1.6           2:1                       
3             2:1                    
4.4           2:1                        
*Total starch+ alginate= 5% (w/v). All samples were prepared in triplicate. 
 
 
Figure 2.1 Absorbance of MRS broth and L. acidophilus growth curve. 
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Figure 2.2 Particles obtained using emulsion method under microscopy.  
 
Figure 2.3 Particles obtained using extrusion method. 
 
  
 
 
 
Chapter 3 Results and discussion 
3.1 Emulsion method 
3.1.1 Choosing wall material composition 
Based on preliminary results (appendix A and B), selected wall materials and 
compositions were chosen to study which compositions would provide the most 
protection to the probiotic cells. For the experiments, alginate levels ranged from 1.6 to 
4.4%, while the potato starch and RS4 ratio was fixed at 2. Encapsulated particles were 
obtained with different wall material compositions with an emulsion method. 
Encapsulated particles were incubated in MRS broth at pH 2 for 3 hours and tested for 
the viability of the probiotic. The wall material compositions and the results obtained for 
cell survivability are presented in Table 3.1. 
 
Table 3.1 Bacterial cell reduction in encapsulated L. acidophilus when particles were 
obtained by the emulsion method after 3 hours incubation in MRS broth at pH 2. 
Wall material composition Reduction (log CFU/g) 
Alginate (%) Potato starch: RS4 Mean (SD) 
1.6 2 3.08 (0.05)
a
 
3 2 2.78 (0.09)
ab
 
4.4 2 2.31 (0.38)
b
 
Free Cells  2.07 (0.25)
b
 
*Different letters within the same column indicate difference based on p<0.05. 
*Mean and standard deviation was obtained with triplicate samples. 
 
The results showed that the least amount of bacterial reduction was achieved with either 
free  cells, 3.0 or 4.4% alginate, with no significant difference between the three 
 
 
 
compositions (p>0.05). However, the survival of the bacterial cells encapsulated with 
3.0% alginate was not different than the reduction observed in particles made with 1.6% 
alginate. Therefore, from an economical stand point, the wall material composition of 
1.6% alginate and potato starch: RS4 ratio of 2 was chosen for further tests. 
 
 
3.1.2 Physical properties of encapsulated particles 
The particle size distribution of encapsulated particles was determined for different wall 
material compositions, with alginate varying from 1.6 to 4.4% and the ratio between 
potato starch and RS4 fixed at 2. Results in Figure 3.1 show that particles prepared with 
3.0 and 4.4% alginate showed one peak, while particles with 1.6% alginate showed two 
peaks. Based on the results, particles with higher alginate level were larger in size. At an 
alginate level of 1.6%, over 90% of the particles had a mean size of 666µm, while at an 
alginate level of 3.0%, over 90% of the particles had a mean size of 586µm. Finally, at an 
alginate level of 4.4%, over 90% of the particles had a mean size of 586µm. 
 
Previous research had reported results regarding levels of alginate and particle size 
distribution. Sheu and Marshall (1993) used light microscopy to measure the particle size 
of encapsulated particles. They reported that the particles containing lactobacilli ranged 
in size from 5-100 µm with means of 25-35µm. When the alginate increased from 0.5 to 
 
 
 
4.5%, the mean particle size increased from 15.4 to 22.1µm. Adhikari et al. (2003)  
measured particles containing B. longum B6 with laser diffractometry and found that the 
particle size was 235.8±25.6 µm, with 91% in the size range of 22 to 350µm.  
 
 
Figure 3.1 Particle size distribution of particles produced by the emulsion method (1.6%, 
3.0%, 4.4%- alginate level; potato starch: RS4=2). 
 
 
3.1.3 Challenging encapsulated L. acidophilus with pH, bile salt and 
temperature  
Encapsulated cells were obtained using the optimized composition for the wall material. 
The survivability of L. acidophilus in the particles after treatment at different pH, 
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different concentrations of bile salt and temperature was compared to free cells. To test 
the performance of the encapsulated and free cells at different pH values, they were 
incubated in MRS broth adjusted to pH 2, 4, and 7. Cell viability was tested after 6, 15, 
and 24 hours. Viability at pH 2 and 4 appeared to decrease as the incubation period 
increased (Figure 3.2). However at pH 7, L. acidophilus showed growth over the 
incubation period, with both encapsulated and free cells. Encapsulated cells increased 1.3 
log CFU/mL more than free cells. At acidic pH values, encapsulated cells showed a 
reduction of 1.18 log CFU/g after 24h of incubation at pH 4, while free cells showed a 
decrease of 2.91 log CFU/mL. Incubation of encapsulated and free cells at pH 2 showed 
that both types of cells did not survive after 24 hours of incubation.  
 
 
 
 
 
 
Figure 3.2 Survivability of encapsulated and free L. acidophilus over 24 hours of 
incubation at different pH values. 
 
These results show that encapsulation by emulsion has only a minimal effect in 
protecting L. acidophilus from the effects of low pH. Encapsulation somewhat protected 
cells at pH 4, but failed to protect the cells at pH 2. These results are in accordance with 
previous published information. Rao et al. (1989), Hansen et al. (2002), Sultana et al. 
(2000), Koo et al. (2001) reported that encapsulation did not provide protection against 
acidic conditions as low as  pH 2. However, Sultana et al. (2000) tested the acid tolerance 
of encapsulated particles at pH 4 after incubation for 3 hours and found 1.71 log CFU/g 
reduction while the free cells showed almost a 5 log decrease.  
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Survival of encapsulated cells and free cells was also tested after 6 hours of incubation in 
MRS broth containing bile salt (0.5, 1.0, and 2.0%). Results shown in Table 3.2 suggest 
that encapsulation may have provided some protection against bile salt; however 
statistical analysis showed no difference between reductions obtained with encapsulated 
and free cells. The encapsulated cells showed a 0.41 log reduction when exposed to 0.5% 
bile salt broth, while the free cells decreased by 1.36 log. The results from 1.0% and 
2.0% bile salt broth showed similar trends, where encapsulated cells were reduced by 
about 0.70 log and free cells by 1.70 log.  
 
 
 
 
 
 
Table 3.2 Reduction in bacterial counts of encapsulated and free L. acidophilus over 6 hours of incubation in bile salt at different 
levels (0.5, 1.0, and 2.0%). 
Bile salt (%) Encapsulated (log CFU/g) Free (log CFU/mL) 
Initial 6 hours Reduction Initial 6 hours Reduction 
 Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
0.5 6.54 (0.54) 6.13 (0.71) 0.41(0.20)b 6.65 (0.18) 5.29 (0.21) 1.35 (0.26)ab 
1.0 6.54 (0.54) 5.79 (0.67) 0.75(0.34)ab 6.65 (0.18) 4.95 (0.31) 1.69 (0.37)a 
2.0 6.54 (0.54) 5.85 (0.79) 0.68(0.75)ab 6.65 (0.18) 4.89 (0.34) 1.75 (0.24)a 
*Different letters within the same row indicate difference based on p<0.05. 
* Mean and standard deviation were obtained from triplicate samples.
 
 
 
Survival of encapsulated and free cells at different temperatures was also tested after 
incubation in MRS broth at 25°C for 24 hours (Table 3.3), at 37°C for 24 hours (Table 
3.4), and at 50 °C for 3 hours (Table 3.5). Cell counts were determined either initially and 
after incubation periods or at set intervals. These results show that none of the 
temperature was detrimental to either encapsulated or free cells. Actually, bacterial 
growth was observed in encapsulated and free cells when incubated at 37°C. The cell 
count of encapsulated and free cells remained stable at 25°C and 50°C. Ding and Shah 
(2007) found that encapsulated  L. acidophilus cells obtained from emulsion method died 
after exposure to 65°C for up to1 hour, indicating that 65°C was the lethal temperature 
for this organism and encapsulation did not improve heat tolerance. 
Table 3.3 Survival of encapsulated and free L. acidophilus after incubation over 24 hours 
incubation in MRS broth at 25°C. 
 Bacterial count (log CFU/g) Bacterial reduction 
(log CFU/g) Initial 3 hours 
Mean (SD) Mean (SD) Mean (SD) 
Encapsulated 6.54 (0.54) 6.85 (0.76) -0.18 (0.27)
a
 
Free 6.65 (0.18) 6.49 (0.22)  0.15 (0.12)
a
 
*Different letters within the same column indicate difference based on p<0.05. 
* Mean and standard deviation was obtained with triplicate samples. 
 
 
Table 3.4 Survival of encapsulated and free L. acidophilus over 24 hours incubation in 
MRS broth at 37°C (log CFU/g). 
 Bacterial counts (log CFU/g) Bacterial reduction 
(log CFU/g)  Initial 6 hour 15 hour 24 hour 
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Encapsulated 6.54 (0.54) 7.58 (0.15) 8.14 (0.80) 8.52 (1.08) -1.97 (1.62)
a
 
Free 6.65 (0.18) 7.45 (0.26) 8.42 (0.30) 8.97 (0.53) -2.29 (0.63)
a
 
*Different letters within the same column indicate difference based on p<0.05. 
* Mean and standard deviation was obtained with triplicate samples. 
 
 
 
Table 3.5 Survival of encapsulated and free L. acidophilus over 3 hours incubation in 
MRS broth at 50°C (log CFU/g) 
 Initial  3 hours  Bacterial 
reduction 
Mean (SD) Mean (SD) Mean (SD) 
Encapsulated 6.54 (0.54) 6.40 (0.69) 0.14 (0.31)
a
 
Free 6.65 (0.18) 6.17 (0.14) 0.46 (0.30)
a
 
*Different letters within the same column indicate difference based on p<0.05. 
* Mean and standard deviation was obtained with triplicate samples. 
 
Based on the results obtained and lack of evidence that encapsulation by emulsion was 
efficient in promoting cell survivability at low pH, and a only a limited effect impacting 
against bile salts was observed, this method of encapsulation was not further studied. 
 
3.2 L. acidophilus encapsulated by the extrusion method 
3.2.1 Wall material composition 
Based on preliminary experiments, selected wall materials and compositions were chosen 
that would provide the most protection to the probiotic cells. For these experiments, 
alginate levels ranged from 1.6 to 4.4%, while the ratio of potato starch and RS4 was 
fixed at 2. Encapsulated particles of different wall material compositions were obtained 
using the extrusion method. Viability of bacterial cells was tested initially and after 3 
hours of incubation in MRS broth at pH 2. The wall material compositions and the results 
obtained for cell survivability are presented in Table 3.6. 
 
 
 
 
Table 3.6 Bacterial cell reduction in encapsulated L. acidophilus after 3 hours incubation 
in MRS broth at pH 2 when particles were obtained by the extrusion method.  
Encapsulated cells Bacterial reduction (log CFU/g) 
Alginate (%) Potato starch: RS4 Mean (SD) 
1.6 2:1 0.29 (0.06)
b
 
3.0 2:1 0.08 (0.09)
bc
 
4.4 2:1 0.02 (0.12)
c
 
Free cell 2.07 (0.25)
a
 
*Different letters within the same column indicate difference based on p<0.05. 
* Mean and standard deviation was obtained with triplicate samples. 
 
These results showed that there was a significant difference in survivability between 
encapsulated and free cells (p<0.05), indicating that encapsulation by extrusion could be 
beneficial. Among alginate levels tested there was no difference between 1.6% and 3.0%.  
However, there was a significant difference between 4.4% and 1.6% level of alginate. 
Based on these results, to obtain the most protection by encapsulation, 4.4% of alginate 
and 2:1 ratio of potato starch: RS 4 were chosen as the optimum wall material 
composition.  
 
3.2.2 Particle size  
The size of the particles encapsulated by the extrusion method was measured and the 
results are shown in Table 3.7. The results indicated that the mean particle diameter 
ranged from 1.22 to 2.61mm when alginate concentration ranged from 1.6 to 4.4%. It 
also indicated that the particle mean diameter would increase with increasing alginate 
concentration. However, no statistical difference was observed among the values 
measured. 
 
 
 
 
The size of the particles produced by extrusion are influenced by factors such as 
concentration of the alginate solution, distance between the syringe and hardening 
solution, and the size of the needle (Smidsrod and Skjakbraek 1990). By comparing 
results with published research done with same the syringe gauge and alginate solution 
used here, similar results were found. Lee and Heo (2000) reported obtaining particles 
with diameters of about 1.03, 1.75, 2.62 mm containing 2, 3, 4% sodium alginate, 
respectively, which also increased with higher alginate concentration.  
 
Table 3.7 Particle size (mean diameter) of the encapsulated particles from extrusion. 
Wall material composition Particle size (mm) 
Alginate (%) Potato starch: RS4 Mean (SD) 
1.6 2 1.22 (0.01)
ab
 
3 2 2.02 (0.01)
a
 
4.4 2 2.61 (0.02)
a
 
*Different letters within the same column indicate difference based on p<0.05. 
* Mean and standard deviation was obtained with triplicate samples. 
 
3.2.3 Hardening time test 
Particles were made with the optimized wall material (4.4% alginate, potato starch: 
RS4=2) and hardened for different time periods (30, 60, 90, and 120 min). Particles were 
then tested for the survivability of encapsulated cells by incubating in MRS broth at pH 2 
for 3 hours. The results shown in Table 3.8 indicated that as the hardening time increased, 
the survival of bacterial cells in the particles started to increase as well. The viability of 
 
 
 
the encapsulated cells in pH 2 decreased by 1.74 log with a 30 min hardening time which 
was a significantly higher difference in reduction than the other ones observed with 
longer hardening times (p<0.05). The reduction in all viability at pH 2 was 0.99, 0.55, 
0.078 log CFU/g, for a hardening time of 60, 90, 120 min, respectively. Based on the 
statistical analysis, a hardening time of 120 min was chosen as the optimum processing 
parameter for the production of the particles. 
 
The results observed here are in accordance with previous research. Chandramouli et al. 
(2004) tested the hardening time when encapsulating L. acidophilus CSCC 2400 with 
alginate, and found a significant increase in survival of bacteria cells when hardening the 
particles for 30 min or more in 0.1M  calcium chloride solutions. They also indicated that 
hardening for 8 hours or more had no effect on increasing viability of the encapsulated 
cells. Also, hardening particles for 12 hours at 4°C did not significantly influence 
viability of encapsulated cells.  
Table 3.8 Effect of hardening time on survival of encapsulated and free L. acidophilus 
after incubation in MRS broth at pH 2 for 3 hours. 
Hardening time (min) Initial 
 (log CFU/g) 
3 hours  
(log CFU/g) 
Reduction 
 (log CFU/g) 
Mean (SD) Mean (SD) Mean (SD) 
30 7.43 (0.35) 5.48 (0.45) 1.74 (0.11)
a
 
60 7.91 (0.12) 6.92 (0.31) 0.99 (0.11)
b
 
90 8.04 (0.50) 7.49 (0.38) 0.55 (0.11)
bc
 
120 8.63 (0.12) 8.55 (0.03) 0.02 (0.11)
c
 
*Different letters within the same column indicate difference based on p<0.05. 
* Mean and standard deviation was obtained with triplicate samples. 
 
 
 
 
3.2.4 Challenging encapsulated L. acidophilus with pH and bile salt test 
Survival of encapsulated and free cells after incubation in MRS broth at pH 2.0, 4.0, 4.5, 
and 5.0 for 24 hours was evaluated and the results are presented in Figure 3.3. Both 
encapsulated and free cells were stable at pH 4, 4.5, and 5.0 with no significant 
differences between reductions obtained for encapsulated cells and free cells (p>0.05). 
However, there was a significant difference between the survival of encapsulated and free 
cells after incubation in pH 2 for 24 hours (p<0.05). Encapsulation remarkably improved 
the acid tolerance of particles at pH 2.  
 
 
 
Figure 3.3 Effect of pH on survival of encapsulated cells (cell reduction) after incubation 
in MRS broth at pH 2.0, 4.0, 4.5, and 5.0 for 24 hours. 
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Encapsulated and free cells were also exposed to different concentrations of bile salt (0.5, 
1.0, and 2.0%) and were tested after 6 hours of incubation. The results in Table 3.9 
indicate that encapsulation provided protection for the cells, since the survival of 
encapsulated cells was significantly better (p<0.05) than that of the free cells. 
Encapsulated L. acidophilus with initial cell load of 8.86 log CFU/g, showed only about 
0.5 log reduction for all bile salt levels tested.   The free cells however showed reduction 
by 1.36-, 1.70-, and 1.76-log for 0.5, 1.0, 2.0% bile salt, respectively. 
 
 
 
 
 
Table 3.9 Bacterial counts of encapsulated and free L. acidophilus over 6 hours of incubation in bile salt at different levels (0.5, 1.0, 
and 2.0%). 
Bile salt 
(%) 
Encapsulated (log CFU/g) Free cell (log CFU/Ml)  
Initial 6 hours Reduction Initial 6 hours Reduction 
 Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
0.5 8.86 (0.14) 8.36 (0.16) 0.50 (0.14)
b
 6.65 (0.18) 5.29 (0.21) 1.36 (0.14)
a
 
1.0 8.86 (0.14) 8.27 (0.11) 0.59 (0.14)
b
 6.65 (0.18) 4.95 (0.31) 1.70 (0.14)
a
 
2.0 8.86 (0.14) 8.35 (0.02) 0.51 (0.14)
b
 6.65 (0.18) 4.89 (0.34) 1.76 (0.14)
a
 
*Different letters within the same column indicate difference based on p<0.05. 
* Mean and standard deviation was obtained with triplicate samples.
 
 
 
 
The results show that encapsulation by the extrusion method gives good protection 
against bile salt. The results related to improved survivability of encapsulated cells 
treated with bile salt obtained in this study are in accordance with previous published 
research (Lee and Heo 2000; Sabikhi et al. 2010).  Murata et al. (1999) found out that 
there was a 1- and 0.8-log decrease  of free L. acidophilus at 1.0% bile salt, while for 
encapsulated cells there was a 0.5 and 0.3 log decrease, for strains CSCC 2400 and CSCC 
2409 respectively, under the same conditions after 6 hours.  It was reported that certain 
stains of L. acidophilus had the ability of conjugating bile acid under anaerobic 
environment  (Gilliland and Speck 1977a). Kim et al. (2008) studied strain of L. 
cidophilus ATCC 43121, which was proved by Gilliland and Walker (1990) to be 
significantly better in bile tolerance than other cultures. Their results showed that 
encapsulated cells survived better in 0.5% bile salt and the free cells decreased from 6.85-
log to 5.96-log, while the encapsulated cells were not affected.   
 
 
 
 
 
 
 
 
 
3.2.5 Challenging survival of encapsulated L. acidophilus under different 
pH and temperature conditions for 7 days 
Because the results from the pH experiment were limited to 24 hours, the exposure time 
to low pH was extended to 7 days to evaluate the long term effect of pH on encapsulated 
cells. Encapsulated and free cells were incubated in MRS broth at pH 4.0, 4.5, 5.0 at 7 
and 25 °C, and were tested every day for 7 days (Figures 3.5 and 3.6). The viability of 
encapsulated cells remained at 8 logs for the 3 different pHs at 7°C. Meanwhile, the free 
cells showed a slight decrease of 2.1-, 1.3-, 1.3-log CFU/mL for pH 4.0, 4.5, 5.0, 
respectively, over time. There was significant difference between encapsulated and free 
cells at pH 4 when incubated at 7°C (p<0.05). When incubation at 25°C was evaluated, 
the encapsulated cells incubated at pH 4.5 and 5.0 remained stable, showing a slight 
decrease of 1.7-and 0.7-log respectively, which was not significantly different from the 
results obtained with free cells (p>0.05). Encapsulated cells incubated at pH 4.0 began to 
die at day 2 and by day 7 a reduction of 5.1 log CFU/g was observed. Despite the 5.0 log 
reduction, encapsulation was significant in protecting L. acidophilus from the effect of 
pH 4.0 since free cells were completely inactivate by day 6 (p<0.05).  
 
 
 
 
 
 
 
 
 
Figure 3.4 Survival of encapsulated and free cells during incubation for 7 days at 7°C. 
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Figure 3.5 Survival of encapsulated and free cells during incubation for 7 days at 25°C. 
 
These results were encouraging because it showed that encapsulation may protect cells 
long term, especially at pH 4.0 at 7 and 25°C. This may allow for the addition of 
encapsulated probiotics to acidic beverages with pH around 4.0. 
 
3.2.6 Survival of encapsulated L. acidophilus in low pH beverages 
Particles were produced and put into food systems to evaluate their performance over a 
16 day shelf life. Based on the results from pH tests over 7 days, encapsulation provided 
good protection when particles were incubated at low pH conditions at 7 and 25°C. 
Therefore, two different products within the same pH range were chosen along with these 
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storage conditions. The two products tested were milk (2% reduced milk, 7°C) and a fruit 
juice (acai juice, 25°C). The particles were put into the products, stored, and tested for 
cell viability after 0, 4, 8, 12, 16 days of shelf life.  The results are shown in Table 3.10. 
 
 
 
 
 
 
 
 
Table 3.10 Survival of encapsulated and free cells in milk and juice (log CFU/g). 
  Cell count (CFU/g) Cell reduction 
(log CFU/g)   Day0 Day4 Day8 Day 12 Day 16 
  Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Milk Encapsulated 8.81 (0.10) 8.71 (0.08) 
 
8.30 (0.35) 
 
7.54 (0.29) 7.03 (0.08) 1.74 (0.21)
b
 
Free 8.26 (0.23) 7.73 (0.32) 
 
7.63 (0.17) 
 
7.60 (0.06) 6.97 (0.00) 1.28 (0.33)
b
 
Juice Encapsulated 8.81 (0.10) 
 
7.62 (0.10) 
 
7.39 (0.11)
 
 
ND ND 8.81 (0.12)
a
 
Free 8.26 (0.23) 
 
6.98 (0.13) 
 
5.54 (0.19) 
 
ND ND 8.26 (0.33)
a
 
*Different letters within the same column indicate difference based on p<0.05. 
*Mean and standard deviation was obtained with duplicated sample. 
*ND:  None detected; limit of detection of <100 CFU.
 
 
 
 
The results indicated that both the encapsulated and free cells placed in milk stayed 
stable. Encapsulated particles showed a decrease of 1.78 log CFU/g in milk after 16 days 
of shelf life, while the free cells showed a decrease of 1.29 log CFU/mL. Overall, for the 
particles in milk, the number of probiotics was maintained above the recommended 
minimum (10
7
 CFU/g) during storage, which was feasible for industry applications. 
 
For the particles in acai juice, the results showed that both encapsulated and free cells 
started to die at day 4. Encapsulation provided protection to some extent at day 4 and  8 
with a 1.19 and 1.42 log CFU/g reduction for encapsulated cells, respectively; while free 
cells suffered a reduction of 1.28  and 2.72 log CFU/mL. However, both encapsulated 
and free cells completely died at day 12. One reason that may explain why both the 
encapsulated and free cells died in the juice was that the pH of the beverage was even 
lower than the pH tested in the MRS broth where protective effects had been observed. 
The beverage also had a low concentration of calcium cation (2%), which can be 
beneficial for the stability of the alginate network.  
 
Similar results have been reported for encapsulated probiotics added to yogurt and stored 
at 4°C. Krasaekoopt et al. (2006) tested the particles in yogurt made from UHT- and 
conventional milk and found that encapsulated cells were reduced by about 1.2 log while 
 
 
 
free cells showed a reduction of 2.5 log after 4 weeks of storage. Ding and Shah (2008) 
tested encapsulated particles in orange and apple juices over 4 weeks of storage. They 
found out that there was a rapid decrease of free cells within four weeks and all the free 
cells died by the fifth week. The encapsulated cells were still detected as high as 10
5 
CFU/g after 6 weeks of storage. The reason why the previous results showed a higher 
survival of the cells might be due to the type of the juice used and strain of the organism. 
The free cells were still alive by the fifth week while the L. acidophilus DDS 1-10 died 
on day 12 (week 2), which indicates that the organism they used were more resistant to 
low pH. Therefore, even though previous research also showed a decline in survivability, 
the rate of cell death was slower than observed in this research. 
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Chapter 4 Conclusions and future research 
4.1 Conclusions 
Alginate-starch matrices were used to encapsulate L. acidophilus DDS 1-10 using an 
emulsion and an extrusion method. For the emulsion method, the optimum wall material 
composition was 1.6% of alginate and potato starch: RS4 in a ratio of 2:1. Particles 
obtained with this method showed a particle size distribution that was not uniform. The 
encapsulation process did not seem to enhance the bacterial resistance to acid conditions. 
Encapsulation by emulsion provided small but not significant protection against bile salt 
(0.5, 1.0, and 2.0%) for up to 6 hours. Regarding temperature, none of the different ones 
tested (25, 37, and 50 °C) was lethal to L. acidophilus (encapsulated and free cells), so 
heat protection by encapsulation was not be observed. Since the encapsulated particles 
did not seem to offer additional protection against pH and bile salts, the emulsion method 
was not studied any further. 
 
The extrusion method seemed to overall provide a better protection for L. acidophilus 
compared to the emulsion method. For this process, the optimum wall material was 
determined to be 4.4% of alginate and potato starch: RS 4 in a ratio of 2:1. The particles 
produced by extrusion were bigger in size than the ones produced by the emulsion 
method, but much more uniform, with a mean diameter of 2.61 mm. The hardening time 
used to produce the particles influenced the survivability of L. acidophilus in the 
 
 
 
particles. Increasing the hardening time during processing, especially when increased to 2 
hours, dramatically increased the stability of the probiotic in the particles. Additionally, 
the encapsulated particles showed significant resistance to bile salt at 0.5, 1.0, and 2.0% 
after 6 hours of incubation. When incubation at pH 4.0, 4.5, and 5.0 for 24 hours at 37°C 
was evaluated, encapsulation did not provide any advantage; since both encapsulated and 
free cells were stable. However, when the testing time was increased to 7 days and the 
temperature was changed to 7 and 25°C, encapsulation was protective for the cells when 
tested at pH 4.0 for both 7 and 25°C. These results indicated the potential to incorporate 
these particles into a system with a pH around 4.0 followed by storage at 7 and 25°C. 
When particles were incorporated into food systems, promising results were obtained 
with milk. When incorporated into this food, the particles maintained counts above or at 
the levels usually observed in foods added with probiotics during 16 days of storage. 
However, the cells were not fully protected in acai juice over the storage period most 
likely due to the low pH of the juice.   
 
4.2 Future work 
Areas of interest to continue with this research include: 
 Further optimization of the encapsulation processing by adding a second layer to 
the existing wall material, i.e. chitosan, gelatin.  
 
 
 
 Further optimization of wall material compositions by including tests with higher 
starch composition. 
 Evaluation of protection provided to L. acidophilus by encapsulation against acid 
and bile using more complex models. 
 Evaluation of protection against temperature provided by encapsulation when 
higher temperature and longer exposure time are used. 
 Freeze drying of the particles to evaluate the survival of L. acidophilus, with the 
potential of adding the dried encapsulated probiotic to a wider variety of food 
products. 
 Incorporation of encapsulated L. acidophilus in other dairy products, like cheese 
and yogurt, as well as in juices with higher pH.  
 Shelf life of encapsulated cells. 
 
 
 
 
 
 
 
 
 
 
 
Appendix A. 
 
Note: The data in Appendix A and B was generated in an attempt to utilize a response-
surface design to find the best wall material combinations. The results were inconsistent 
and did not show any obvious patterns. Therefore this design was abandoned and 
replaced by a simple model that is described in the thesis under materials and methods. 
 
Bacterial reduction of encapsulated particles produced from 
emulsion method after incubation in MRS at pH 2 for 3 hours  
Alginate (%) Potato starch : RS4 Ratio Reduction (log CFU/g) 
Mean (SD) 
1.6 2:1 3.08 (0.05) 
3 2:1  2.78 (0.09)  
4.4 2:1 2.31 (0.38) 
2 1:1 1.36 (0.45) 
2 3:1 2.79 (0.07) 
4 1:1 2.47 (0.46) 
4 3:1 1.58 (0.46) 
3 3:5 3.17 (0.28) 
3 24:7 3.32 (0.02) 
*All samples were done with duplicate, 3% of alginate, ratio of potato starch: RS4 at 2:1 was  
done with 5 runs. 
 
 
 
 
 
 
 
Appendix B. 
 
Bacterial reduction of encapsulated particles produced from 
extrusion method after incubation in MRS at pH 2 for 3 hours. 
 
Alginate Potato: RS4 Ratio Reduction (Log CFU/g) 
Mean (SD) 
1.6 2:1 2.09 (0.46) 
3 2:1 1.97 (0.35) 
4.4 2:1 1.74 (0.11) 
2 1:1 1.87 (0.01) 
2 3:1 1.66 (0.89) 
4 1:1 1.90 (0.03) 
4 3:1 1.28 (0.30) 
3 3:5 2.23 (0.03) 
3 24:7 2.10 (0.06) 
*All samples were done with duplicate, 3% of alginate, ration of potato starch: RS4 at 2:1  
was done with 5 runs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
